Literature DB >> 28351211

Salivary lactoferrin is transferred into the brain via the sublingual route.

Takashi Hayashi1, Masahiro To2, Juri Saruta1, Chikatoshi Sato3, Yuko Yamamoto4, Yusuke Kondo1,5, Tomoko Shimizu3, Yohei Kamata3, Keiichi Tsukinoki1.   

Abstract

Lactoferrin (LF) is produced by exocrine glands including salivary gland, and has various functions including infection defense. However, the transfer of LF from peripheral organs into the brain remains unclear. To clarify the kinetics of salivary LF (sLF), we investigated the consequences of sialoadenectomy and bovine LF (bLF) sublingual administration in rats. The salivary glands were removed from male Wistar rats, and we measured rat LF levels in the blood and brain at 1 week post-surgery. We also examined the transfer of LF into the organs of the rats after sublingual administration of bLF. Rat LF levels in the blood and brain were significantly reduced by sialoadenectomy. Sublingual bLF administration significantly increased bLF levels in the brain, which then decreased over time. These results indicate that LF is transferred from the sublingual mucosa to the brain, in which favorable effects of sLF on brain will be expected via the sublingual mucosa.

Entities:  

Keywords:  administration; brain; lactoferrin; salivary gland; sublingual

Mesh:

Substances:

Year:  2017        PMID: 28351211     DOI: 10.1080/09168451.2017.1308241

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  7 in total

Review 1.  Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer's Disease Patients.

Authors:  Fernando Bartolomé; Luigi Rosa; Piera Valenti; Francisco Lopera; Jesús Hernández-Gallego; José Luis Cantero; Gorka Orive; Eva Carro
Journal:  Front Immunol       Date:  2022-04-25       Impact factor: 8.786

Review 2.  Lactoferrin in a Context of Inflammation-Induced Pathology.

Authors:  Marian L Kruzel; Michal Zimecki; Jeffrey K Actor
Journal:  Front Immunol       Date:  2017-11-06       Impact factor: 7.561

3.  Decreased salivary lactoferrin levels are specific to Alzheimer's disease.

Authors:  Marta González-Sánchez; Fernando Bartolome; Desiree Antequera; Veronica Puertas-Martín; Pilar González; Adolfo Gómez-Grande; Sara Llamas-Velasco; Alejandro Herrero-San Martín; David Pérez-Martínez; Alberto Villarejo-Galende; Mercedes Atienza; Miriam Palomar-Bonet; Jose Luis Cantero; George Perry; Gorka Orive; Borja Ibañez; Hector Bueno; Valentin Fuster; Eva Carro
Journal:  EBioMedicine       Date:  2020-06-22       Impact factor: 8.143

4.  Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity.

Authors:  Wakako Sakaguchi; Nobuhisa Kubota; Tomoko Shimizu; Juri Saruta; Shinya Fuchida; Akira Kawata; Yuko Yamamoto; Masahiro Sugimoto; Mayumi Yakeishi; Keiichi Tsukinoki
Journal:  Int J Mol Sci       Date:  2020-08-20       Impact factor: 5.923

5.  Salivary Lactoferrin Expression in a Mouse Model of Alzheimer's Disease.

Authors:  Desiree Antequera; Diego Moneo; Laura Carrero; Fernando Bartolome; Isidro Ferrer; Gordon Proctor; Eva Carro
Journal:  Front Immunol       Date:  2021-09-30       Impact factor: 7.561

6.  Detection of cross-reactive immunoglobulin A against the severe acute respiratory syndrome-coronavirus-2 spike 1 subunit in saliva.

Authors:  Keiichi Tsukinoki; Tatsuo Yamamoto; Keisuke Handa; Mariko Iwamiya; Juri Saruta; Satoshi Ino; Takashi Sakurai
Journal:  PLoS One       Date:  2021-11-23       Impact factor: 3.240

Review 7.  Lactoferrin's Anti-Cancer Properties: Safety, Selectivity, and Wide Range of Action.

Authors:  Antimo Cutone; Luigi Rosa; Giusi Ianiro; Maria Stefania Lepanto; Maria Carmela Bonaccorsi di Patti; Piera Valenti; Giovanni Musci
Journal:  Biomolecules       Date:  2020-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.